Trupanion (NASDAQ:TRUP) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Trupanion (NASDAQ:TRUP) released its quarterly earnings data on Wednesday. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05, FiscalAI reports. Trupanion had a net margin of 1.53% and a return on equity of 6.07%. The company had revenue of $392.93 million for the quarter, compared to analysts’ expectations of $389.72 million. During the same quarter in the prior year, the firm earned $0.22 EPS. The business’s revenue was up 11.1% on a year-over-year basis.

Here are the key takeaways from Trupanion’s conference call:

• Subscription performance strengthened: Subscription adjusted operating income rose 24% year over year to $41.4 million, with a 15% margin, while subscription pets increased 5% to 1.125 million and retention improved to 98.37%.
• Improved acquisition economics helped drive a 9% increase in gross pet adds and 39% growth in net subscription pet additions. Management said enrolled-pet lifetime value increased 25%, supporting continued investment in customer acquisition.
• Trupanion authorized a $100 million share repurchase program after securing approval to transfer $44 million from an insurance subsidiary, adding buybacks to its capital-allocation options alongside growth investments and debt repayment.
• Management narrowed full-year 2026 guidance to $1.584 billion-$1.601 billion in revenue and $176 million-$184 million in adjusted operating income, implying approximately 19% adjusted operating income growth at the midpoint.
• Veterinary inflation remains at double-digit levels, while industry reports indicate fewer new veterinary visits; management also disclosed that its relationship with Pets Best will end after the third quarter of 2028.

Trupanion Stock Performance

Shares of NASDAQ:TRUP traded down $0.95 during midday trading on Friday, reaching $27.20. The company had a trading volume of 228,984 shares, compared to its average volume of 424,295. The company’s 50 day moving average price is $24.62 and its 200 day moving average price is $26.17. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The stock has a market cap of $1.19 billion, a P/E ratio of 51.33 and a beta of 1.39. Trupanion has a 52-week low of $21.16 and a 52-week high of $57.00.

Insider Buying and Selling

In other news, CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total transaction of $137,005.86. Following the completion of the sale, the chief financial officer owned 2,081 shares in the company, valued at $46,156.58. This trade represents a 74.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Steve Weinrauch sold 6,674 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $22.00, for a total transaction of $146,828.00. Following the sale, the executive vice president owned 78,062 shares of the company’s stock, valued at approximately $1,717,364. The trade was a 7.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 17,807 shares of company stock worth $394,452. Insiders own 5.58% of the company’s stock.

Hedge Funds Weigh In On Trupanion

Institutional investors and hedge funds have recently bought and sold shares of the company. Royal Bank of Canada lifted its position in shares of Trupanion by 60.6% during the 1st quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock valued at $1,109,000 after buying an additional 11,233 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Trupanion by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock valued at $731,000 after purchasing an additional 858 shares during the last quarter. Millennium Management LLC boosted its position in Trupanion by 73.5% during the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock worth $9,987,000 after purchasing an additional 113,490 shares during the period. Invesco Ltd. increased its stake in shares of Trupanion by 35.1% in the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock worth $10,392,000 after purchasing an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC purchased a new position in shares of Trupanion in the second quarter worth about $249,000.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on TRUP shares. Stifel Nicolaus set a $28.00 target price on shares of Trupanion in a research note on Friday, June 26th. Cantor Fitzgerald dropped their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Atlantic Securities set a $42.00 price target on shares of Trupanion in a report on Wednesday, July 15th. Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Finally, Bank of America decreased their price objective on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Trupanion has a consensus rating of “Moderate Buy” and an average target price of $41.60.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.